On 23 October, Karl Tobieson bought 10,000 shares in life sciences investment company Linc, where he is CEO. The shares were bought at a price of SEK 70.00 per share. The purchase price amounts to SEK 700,000.
This is disclosed in the Swedish Financial Supervisory Authority’s insider register.
